Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan

World Health Organization, 2020 Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 10.1001/jama.2020.1585 Holshue, 2020, First case of 2019 novel coronavirus in the United States, N Engl J Med, 10.1056/NEJMoa2001191 Zumla, 2016, Coronaviruses - drug discovery and therapeutic options, Nat Rev Drug Discov, 15, 327, 10.1038/nrd.2015.37 2020 Groneberg, 2005, Treatment and vaccines for severe acute respiratory syndrome, Lancet Infect Dis, 5, 147, 10.1016/S1473-3099(05)70022-0 Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res Yao, 2020, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Clin Infect Dis, 10.1093/cid/ciaa237 Gautret, 2020, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents, 10.1016/j.ijantimicag.2020.105949 Warren, 2016, Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys, Nature, 531, 381, 10.1038/nature17180 Sheahan, 2020, Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV, Nat Commun, 11, 222, 10.1038/s41467-019-13940-6 Cao, 2020, A trial of lopinavir–ritonavir in adults hospitalized with severe covid-19, N Engl J Med, 10.1056/NEJMoa2001282 Chu, 2004, Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings, Thorax, 59, 252, 10.1136/thorax.2003.012658 Chan, 2003, Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicenter retrospective matched cohort study, Hong Kong Med J, 9, 399 Chan, 2015, Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset, J Infect Dis, 212, 1904, 10.1093/infdis/jiv392 Arabi, 2018, Treatment of Middle East respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial, Trials, 19, 81, 10.1186/s13063-017-2427-0 Li, 2003, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, 426, 450, 10.1038/nature02145 Lai, 2020, Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths, J Microbiol Immunol Infect, 53, 404, 10.1016/j.jmii.2020.02.012